We are live on
!
Find out more
FLSM
Frazier Life Sciences Management Portfolio holdings
AUM
$3.89B
1-Year Est. Return
201.1%
This Fund
S&P 500
This Quarter
Est. Return
-9.64%
1 Year Est. Return
+201.1%
3 Year Est. Return
+879.31%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$1.17B
AUM Growth
–
Cap. Flow
+$1.17B
Cap. Flow
% of AUM
100.06%
Top 10 Holdings %
Top 10 Hldgs %
60.23%
Holding
42
New
42
Increased
–
Reduced
–
Closed
–
Top Buys
| 1 |
Arcutis Biotherapeutics
ARQT
|
+$143M |
| 2 |
Phathom Pharmaceuticals
PHAT
|
+$94.1M |
| 3 |
Mirum Pharmaceuticals
MIRM
|
+$72.8M |
| 4 |
SRRA
Sierra Oncology, Inc. Common Stock
SRRA
|
+$67.2M |
| 5 |
IMGO
Imago BioSciences, Inc. Common stock
IMGO
|
+$61.6M |
Top Sells
No sells this quarter
Sector Composition
| 1 | Healthcare | 98.72% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Arcutis Biotherapeutics
ARQT
$3.47B
| $162M | 13.84% |
+8,434,232
| New | +$143M |
|
|
2
Phathom Pharmaceuticals
PHAT
$875M
| $79.3M | 6.76% |
+5,827,415
| New | +$94.1M |
|
|
3
Mirum Pharmaceuticals
MIRM
$7.16B
| $78.5M | 6.69% |
+3,566,912
| New | +$72.8M |
|
|
SRRA
4
DELISTED
Sierra Oncology, Inc. Common Stock
SRRA
| $75.1M | 6.4% |
+2,342,198
| New | +$67.2M |
|
5
Krystal Biotech
KRYS
$10.1B
| $57.6M | 4.91% |
+866,250
| New | +$54.1M |
|
|
IMGO
6
DELISTED
Imago BioSciences, Inc. Common stock
IMGO
| $57.3M | 4.88% |
+2,971,274
| New | +$61.6M |
|
7
Vaxcyte
PCVX
$8.09B
| $55.8M | 4.75% |
+2,309,554
| New | +$50.5M |
|
8
Syndax Pharmaceuticals
SNDX
$2.01B
| $55.5M | 4.73% |
+3,195,403
| New | +$53.8M |
|
|
KDNY
9
DELISTED
Chinook Therapeutics, Inc. Common Stock
KDNY
| $44.4M | 3.78% |
+2,712,041
| New | +$36.9M |
|
|
ISEE
10
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
| $40.8M | 3.47% |
+2,421,563
| New | +$35.8M |
|
|
ALPN
11
DELISTED
Alpine Immune Sciences Inc
ALPN
| $37.5M | 3.2% |
+4,185,757
| New | +$36.2M |
|
12
Viridian Therapeutics
VRDN
$1.99B
| $32.2M | 2.74% |
+1,739,530
| New | +$33.4M |
|
13
Crinetics Pharmaceuticals
CRNX
$8.88B
| $31.1M | 2.65% |
+1,414,823
| New | +$28.6M |
|
|
BCYC
14
Bicycle Therapeutics
BCYC
$292M
| $26.5M | 2.26% |
+603,521
| New | +$28.2M |
|
15
Tarsus Pharmaceuticals
TARS
$2.52B
| $23.8M | 2.03% |
+1,417,157
| New | +$26.3M |
|
|
KALV
16
DELISTED
KalVista Pharmaceuticals
KALV
| $23.2M | 1.98% |
+1,572,192
| New | +$22.6M |
|
17
AnaptysBio
ANAB
$1.6B
| $22.3M | 1.9% |
+899,700
| New | +$27.2M |
|
|
GRTS
18
DELISTED
Gritstone bio, Inc. Common Stock
GRTS
| $21.6M | 1.84% |
+5,237,348
| New | +$27.7M |
|
19
Cogent Biosciences
COGT
$6.48B
| $19.9M | 1.69% |
+2,651,754
| New | +$18.5M |
|
20
Arvinas
ARVN
$518M
| $18.2M | 1.55% |
+270,331
| New | +$18.4M |
|
|
TCDA
21
DELISTED
Tricida, Inc. Common Stock
TCDA
| $17.1M | 1.46% |
+2,082,093
| New | +$18.8M |
|
|
SLN
22
Silence Therapeutics
SLN
$516M
| $16.7M | 1.43% |
+881,173
| New | +$17.6M |
|
|
MRUS
23
DELISTED
Merus
MRUS
| $16.6M | 1.42% |
+628,979
| New | +$16.9M |
|
|
AUTL
24
Autolus Therapeutics
AUTL
$389M
| $15.6M | 1.33% |
+3,746,857
| New | +$15.8M |
|
25
Passage Bio
PASG
$15.8M
| $15.5M | 1.32% |
+250,461
| New | +$20.6M |
|
Similar funds
GAMH
MSI
CCM
TFM
SCM
MIM
AA
DACG